A Ashfield

Ninewells Hospital — United Kingdom

Medicine · Health Sciences

6h-index468citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(4), HER2/EGFR in Cancer Research(4), Breast Cancer Treatment Studies(3), RNA modifications and cancer(2), Prostate Cancer Diagnosis and Treatment(1)

Publications12 total

Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP
Cell Stress and Chaperones·2022· 5 citedOpen Access
CGA DELIVERY FOR OLDER PATIENTS WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
Journal of Geriatric Oncology·2019· 1 cited
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study
British Journal of Cancer·2013· 186 citedOpen Access
P4-02-06: Progesterone Receptor Expression Predicts Poor Outcome in Estrogen Receptor Positive, Lymph Node Negative Breast Cancer – A Population Based Study.
Cancer Research·2011
FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype
BMC Research Notes·2011· 29 citedOpen Access
Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
British Journal of Cancer·2010· 44 citedOpen Access
An integrated informatics platform to facilitate transforming tissue into knowledge
Breast Cancer Research·2010· 2 citedOpen Access
p53 mutation, deprivation and poor prognosis in primary breast cancer
British Journal of Cancer·2010· 60 citedOpen Access
High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer
International Journal of Cancer·2009· 93 cited
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
BMC Cancer·2008· 47 citedOpen Access
Novel Mdm2 intron 1 single nucleotide polymorphisms and their role in breast cancer
Discovery Research Portal (University of Dundee)·2007
The clinical relevance of p53 isoforms modifying the effects of p53 mutation on survival from breast cancer
Journal of Clinical Oncology·2007· 1 cited

Frequent Co-authors

Philip Quinlan(9), Colin A. Purdie(7), Lee D. Baker(7), Lee B. Jordan(6), Alastair M. Thompson(6), J A Dewar(3), Alastair M. Thompson(2), Nancy Patten(2), Jean‐Christophe Bourdon(2), F. Paulin(2), G. McGregor(2), Alastair J. Munro(2), David P. Lane(2), Susan E. Bray(2), AM Thompson(2), S. Ogston(1), Pankaj Roy(1), Norman Pratt(1), L-J Birse-Stewart-Bell(1), Colin McCowan(1)